Website intended for a NZ health professional readership
Specialist GP Ngaire Kerse discusses recent research in the dementia/delirium field, which highlights the importance of awareness and prevention
1. Ma’u E, Cullum S, Cheung G, et al. Differences in the potential for dementia prevention between major ethnic groups within one country: A cross sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand. Lancet Reg Health West Pac 2021;13:100191.
2. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396(10248):413–46.
3. Menzies O, Dudley M, Garrett N, et al. He Tūhononga Whaiaro: A kaupapa Māori approach to mate wareware (dementia) and cognitive assessment of older Māori. J Appl Gerontol 2022;41(4):1066–73.
4. Gibb K, Seeley A, Quinn T, et al. The consistent burden in published estimates of delirium occurrence in medical inpatients over four decades: a systematic review and meta-analysis study. Age Ageing 2020;49(3):352–60.
5. Tsui A, Searle SD, Bowden H, et al. The effect of baseline cognition and delirium on long-term cognitive impairment and mortality: a prospective population-based study. Lancet Healthy Longev 2022;3(4):e232–41.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
